CARGO Therapeutics, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRGX and other ETFs, options, and stocks.About CRGX
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy.
CEOAnup Radhakrishnan
CEOAnup Radhakrishnan
Employees167
Employees167
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2019
Founded2019
Employees167
Employees167
CRGX Key Statistics
Market cap209.13M
Market cap209.13M
Price-Earnings ratio-0.96
Price-Earnings ratio-0.96
Dividend yield—
Dividend yield—
Average volume2.29M
Average volume2.29M
High today$4.50
High today$4.50
Low today$4.45
Low today$4.45
Open price$4.47
Open price$4.47
Volume667.61K
Volume667.61K
52 Week high$25.45
52 Week high$25.45
52 Week low$3.00
52 Week low$3.00
People also own
Based on the portfolios of people who own CRGX. This list is generated using Robinhood data, and it’s not a recommendation.